Dr. Pourhassan has said he acquired the company in
Post# of 148169
While I realize Leronlimab (Vyrologix) was relatively really close to getting to market, think this tragic CV-19 took over and paved the way to much more... the reputation of these companies has grown and strengthened exponentially (CytoDyn-Dr. Pourhassan, IncellDX-Dr. patterson, Quest Clinical Research-Dr. Lalezari)... I'm naming these particular men but as we all know, it takes teams and lots of folks to brainstorm and do the legwork necessary... my hat's off to all of them!!!
Side note: In my short (long) eight years in OTC and even long (longer) 30+ years in the markets (regarding particular securities I've been involved in/with) I have never before seen a PR come out like the one this morning in terms of timing or should I say in the middle of the night (1:24, really?)... ahaha